Florence Joly

7PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursArt criticism
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 05, 2026
Ovarian cancer.

Clare L Scott, Susana Banerjee, Florence Joly

|Jan 06, 2026
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial.

Isabelle Ray-Coquard, Marie-Christine Kaminsky-Forrett, Ryotaro Ohkuma

|Dec 23, 2025
Impact of androgen receptor pathway inhibitors on cognitive function in older adults treated for metastatic prostate cancer.

Antoine Boué, Giulia Baciarello, Emmanuel Meyer

|Sep 16, 2025
Prevention and management of PARP inhibitor-related haematological toxicities in prostate cancer: French expert opinion using the Delphi method.

Ophélie Cassuto, Romain Mathieu, Carole Helissey

|Aug 26, 2025
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial.

Florence Joly, Alexandra Leary, Isabelle Ray-Coquard

|Apr 30, 2022
Impact of creative art therapy on fatigue and quality of life in patients treated for localized breast cancer: A randomized study.

Florence Joly, David Pasquier, Christelle Levy

Pageof 2

Frequent Collaborators

2 joint publications

Christelle Levy

2 joint publications

Isabelle Ray-Coquard

1 joint publications

Joy Perrier

1 joint publications

Béatrice Desgranges